We read with interest the work by Espino-y-Sosa and colleagues [1], who recently reported that the Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) ratio could be a good predictor of adverse outcomes, including pneumonia, intensive care unit (ICU) admission, intubation, viral sepsis, and death, among pregnant women with COVID-19. The gene discussed is AGT; the disease is COVID-19.